SG10201913141UA - Treatment of alphavirus-induced inflammation - Google Patents

Treatment of alphavirus-induced inflammation

Info

Publication number
SG10201913141UA
SG10201913141UA SG10201913141UA SG10201913141UA SG10201913141UA SG 10201913141U A SG10201913141U A SG 10201913141UA SG 10201913141U A SG10201913141U A SG 10201913141UA SG 10201913141U A SG10201913141U A SG 10201913141UA SG 10201913141U A SG10201913141U A SG 10201913141UA
Authority
SG
Singapore
Prior art keywords
alphavirus
treatment
induced inflammation
inflammation
induced
Prior art date
Application number
SG10201913141UA
Inventor
Surendran Mahalingam
Lara Josefina Herrero
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Griffith filed Critical Univ Griffith
Priority to SG10201913141UA priority Critical patent/SG10201913141UA/en
Publication of SG10201913141UA publication Critical patent/SG10201913141UA/en

Links

SG10201913141UA 2016-05-26 2016-05-26 Treatment of alphavirus-induced inflammation SG10201913141UA (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG10201913141UA SG10201913141UA (en) 2016-05-26 2016-05-26 Treatment of alphavirus-induced inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201913141UA SG10201913141UA (en) 2016-05-26 2016-05-26 Treatment of alphavirus-induced inflammation

Publications (1)

Publication Number Publication Date
SG10201913141UA true SG10201913141UA (en) 2020-03-30

Family

ID=70615282

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201913141UA SG10201913141UA (en) 2016-05-26 2016-05-26 Treatment of alphavirus-induced inflammation

Country Status (1)

Country Link
SG (1) SG10201913141UA (en)

Similar Documents

Publication Publication Date Title
ZA202006746B (en) Methods of treatment
IL283258A (en) Treatment of hypoparathyroidism
HK1254287A1 (en) Treatment of fibrosis
FI3851537T3 (en) Treatment of hyperbilirubinemia
SG11201609652RA (en) Treatment of polybacterials infections
HK1244711A1 (en) Treatment of hmgb1-mediated inflammation
HK1249865B (en) Treatment of pain
GB201516905D0 (en) Treatment of Neurodegenerative diseases
HK1249866A1 (en) Methods of treatment with taselisib
GB201607388D0 (en) Treatment of impulsivity-related disorders
SI3302499T1 (en) Treatment of mitochondrial diseases
GB201412010D0 (en) Treatment of hypertransaminasemia
SG11202005850VA (en) Methods of treatment of hypertrigl yceridemia
GB201512139D0 (en) Methods of treatment
SG10201913141UA (en) Treatment of alphavirus-induced inflammation
GB201816914D0 (en) Treatment of inflammation
GB201603755D0 (en) Treatment of hypothyroidism
GB201603752D0 (en) Treatment of hypothyroidism
GB201516418D0 (en) Treatment of acute inflammatory disorders
GB201516140D0 (en) Treatment of acute inflammatory disorders
GB201512723D0 (en) Treatment of cancer
GB201507928D0 (en) Treatment of cancer
GB201504617D0 (en) Treatment of cancer
PT3851537T (en) Treatment of hyperbilirubinemia